Clinical Trials Logo

Cancer, Fallopian Tube clinical trials

View clinical trials related to Cancer, Fallopian Tube.

Filter by:
  • None
  • Page 1

NCT ID: NCT03030287 Completed - Cancer Ovaries Clinical Trials

A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer

Start date: December 2016
Phase: Phase 1
Study type: Interventional

The purpose of this study is to test the efficacy and safety of an experimental drug, OMP-305B83, when given in combination with paclitaxel. OMP-305B83 is a humanized monoclonal antibody and was developed to target cancer stem cells. Based on preclinical studies, it is believed that OMP-305B83 may block the growth of cancer stem cells and may also impair the productive growth of new blood vessels, which tumors need to grow and spread.